We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
HORIZON (OP-106) Study of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety.
- Authors
Richardson, Paul G.; Oriol, Albert; Larocca, Alessandra; Otero, Paula Rodriguez; Norkin, Maxim; Bladé, Joan; Cavo, Michele; Hassoun, Hani; Leleu, Xavier; Alegre, Adrián; Maisel, Christopher; Paner, Agne; Mazumder, Amitabha; Zonder, Jeffrey A.; Puig, Noemí; Harran, John; Harmenberg, Johan; Thuresson, Sara; Zubair, Hanan; Mateos, Maria-Victoria
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pS329
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2019.07.318